Author: Stephanie Figon, MS, RDN, LD

Creator of Supplement Sciences and NutriScape.NET. As a dietitian since 1992, Steph has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. Log in to comment and save this article on your board or send your comments to reviews@supplement-sciences.com

SGLT-2 Webinar on Demand

SGLT-2 Webinar on Demand

Diabetes Series LiveHere’s the Link to the Webinar.

Description:

SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes: Methodology and Monitoring Impact

Speakers

 

Richard Beaser, MD

Associate Professor of Medicine

Harvard Medical School

 

 

Nuha El Sayed, MD

Director-International Training Programs

Joslin Diabetes Center

PROGRAM INFO

Topics Of Interest

The role of the kidney as a treatment target for glycemic control of type 2 diabetes

The mechanism of action and indications of use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Strategies to assess the risk/benefit ratio of SGLT-2 inhibitors for their optimal and safe utilization

Patient assessment, methods for initiation and titration and adverse effect monitoring for appropriate integration of SGLT-2 inhibitors as part of a therapeutic strategy for type 2 diabetes

Jointly provided by Primary Care Network and PlatformQ Health Education, LLC.

This session has been approved for 1.0 AMA PRA Category 1 Credit™.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network and PlatformQ Health Education, LLC. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.

Tuition

Complimentary

Credit Designation Statements

Live Online Activity

Primary Care Network designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Online On-Demand Enduring Material

Primary Care Network designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other health care professionals will be issued a certificate of participation.

Primary Care Network has been awarded Accreditation with Commendation (2013-2019) by the Accreditation Council for Continuing Medical Education (ACCME).

 

New in Type 2

New in Type 2

stomach-1051854_640In an article in Diabetes Care, we have a report on a new method for controlling type 2.

“The gastrointestinal tract plays a major role in the physiologic regulation of glucose metabolism, so it is plausible that gastrointestinal changes in response to years of exposure to certain foods might contribute to the development of metabolic diseases, especially type 2 diabetes. There is now a solid biological rationale to consider the gastrointestinal tract as an ideal target for anti-diabetes interventions.  In fact, recently recognized new guidelines from international diabetes organizations recommend the use of gastrointestinal surgery as a standard treatment option in certain patients with type 2 diabetes.  However, because surgery is not suitable as mass treatment for the hundreds of millions of patients suffering from diabetes, less invasive approaches that harness the mechanisms of major surgery and reproduce some of its beneficial effects could provide a real opportunity for improvement of diabetes care. The early results with Revita DMR are quite encouraging in this regard,” said Dr. Francesco Rubino of London’s King’s College Hospital.

Anti-Monsanto

monsanto-152587_640Many people knowledgeable about food production systems are concerned about the power of large corporations that provide our food.  This site is critical of Monsanto.